Fentanyl Sandoz Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

fentanyl sandoz

sandoz new zealand limited - fentanyl 6.3mg;   - transdermal patch - 37 mcg/h - active: fentanyl 6.3mg   excipient: durotak 87-4287 pegoterate   - the management of chronic cancer pain. the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

Fentanyl Sandoz Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

fentanyl sandoz

sandoz new zealand limited - fentanyl 8.4mg;   - transdermal patch - 50 mcg/h - active: fentanyl 8.4mg   excipient: durotak 87-4287 pegoterate   - the management of chronic cancer pain. the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

Fentanyl Sandoz Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

fentanyl sandoz

sandoz new zealand limited - fentanyl 12.6mg;   - transdermal patch - 75 mcg/h - active: fentanyl 12.6mg   excipient: durotak 87-4287 pegoterate   - the management of chronic cancer pain. the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.

Androderm Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

androderm

teva pharma (new zealand) limited - testosterone 1.41%{relative} (12.2mg/system);   - transdermal patch - 12.2 mg - active: testosterone 1.41%{relative} (12.2mg/system)   excipient: ethanol glycerol glyceryl mono-oleate carbomer copolymer (type b) methyl laurate purified water sodium hydroxide - androderm® is indicated for testosterone replacement therapy for confirmed testosterone deficiency in males.

Androderm Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

androderm

teva pharma (new zealand) limited - testosterone 24.3mg;   - transdermal patch - 24.3 mg - active: testosterone 24.3mg   excipient: ethanol glycerol glycerol mono-oleate carbomer copolymer type b methyl laurate purified water sodium hydroxide - androderm® is indicated for testosterone replacement therapy for confirmed testosterone deficiency in males.

ORILISSA- elagolix tablet, film coated États-Unis - anglais - NLM (National Library of Medicine)

orilissa- elagolix tablet, film coated

abbvie inc. - elagolix sodium (unii: 5948vui423) (elagolix - unii:5b2546mb5z) - orilissa is indicated for the management of moderate to severe pain associated with endometriosis. limitation s of use:   limit the duration of use based on the dose and coexisting condition (see table 1) [see d osage and administration ( 2.1 ) and warnings and precautions ( 5.1 ) ] . orilissa is contraindicated in women: ● who are pregnant [see use in specific populations ( 8.1 )] . exposure to orilissa early in pregnancy may increase the risk of early pregnancy loss. ● with known osteoporosis because of the risk of further bone loss [see warnings and precautions ( 5.1 )] ● with severe hepatic impairment [see use in specific populations ( 8.7 ), clinical pharmacology ( 12.3 )] ● taking inhibitors of organic anion transporting polypeptide (oatp)1b1 (a hepatic uptake transporter) that are known or expected to significantly increase elagolix plasma concentrations [see drug interactions ( 7.2 )]   ● with known hypersensitivity reaction to orilissa or any of its inactive components. reactions have included ana

MELISSA OFFICINALIS pellet États-Unis - anglais - NLM (National Library of Medicine)

melissa officinalis pellet

washington homeopathic products - melissa - to relieve the symptoms of sleeplessness indications: melissa sleeplessness if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

MELISSA OFFICINALIS liquid États-Unis - anglais - NLM (National Library of Medicine)

melissa officinalis liquid

washington homeopathic products - melissa - to relieve the symptoms of sleeplessness. indications: melissa sleeplessness if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

SANDOZ FENTANYL PATCH Canada - anglais - Health Canada

sandoz fentanyl patch

sandoz canada incorporated - fentanyl - patch - 12mcg - fentanyl 12mcg - opiate agonists

SANDOZ FENTANYL PATCH Canada - anglais - Health Canada

sandoz fentanyl patch

sandoz canada incorporated - fentanyl - patch - 25mcg - fentanyl 25mcg - opiate agonists